✦ LIBER ✦

O14 USE OF SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION FOR TREATMENT OF HCV GENOTYPE-1 IN PATIENTS COINFECTED WITH HIV

✍ Scribed by Osinusi, A.; Townsend, K.; Nelson, A.; Kohli, A.; Gross, C.; Polis, M.A.; Pang, P.S.; Symonds, W.T.; Talwani, R.; Sajadi, M.M.; Hogan, J.; Benator, D.; Subramanian, M.; Mchutchison, J.; Masur, H.; Kottilil, S.

Book ID: 122127494
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 102 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60016-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O6 SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMB

O6 SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION IS SAFE AND EFFECTIVE IN DIFFICULT-TO-TREAT POPULATIONS INCLUDING GENOTYPE-3 PATIENTS, DECOMPENSATED GENOTYPE-1 PATIENTS, AND GENOTYPE-1 PATIENTS WITH PRIOR SOFOSBUVIR TREATMENT EXPERIENCE

✍ Gane, E.J.; Hyland, R.H.; An, D.; Pang, P.S.; Symonds, W.T.; Mchutchison, J.G.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 80 KB

O164 ALL ORAL FIXED-DOSE COMBINATION SOF

O164 ALL ORAL FIXED-DOSE COMBINATION SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN FOR 12 OR 24 WEEKS IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-1 STUDY

✍ Mangia, A.; Marcellin, P.; Kwo, P.; Foster, G.R.; Buti, M.; Bräu, N.; Muir, A.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 170 KB

O109 ALL ORAL FIXED-DOSE COMBINATION SOF

O109 ALL ORAL FIXED-DOSE COMBINATION SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN FOR 12 OR 24 WEEKS IN TREATMENT-EXPERIENCED GENOTYPE 1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-2 STUDY

✍ Afdhal, N.; Reddy, R.K.; Pockros, P.; Di Bisceglie, A.M.; Arora, S.; Yang, J.C.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Tu2038 All Oral Fixed-dose Combination S

Tu2038 All Oral Fixed-dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Naive Genotype 1 HCV-Infected Patients: The Phase 3 ION-1 Study

✍ Jacobson, Ira M.; Marcellin, Patrick; Mangia, Alessandra; Kwo, Paul Y.; Foster, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 46 KB

All-oral combination of ledipasvir, vedr

All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection

✍ Wyles, David L.; Rodriguez-Torres, Maribel; Lawitz, Eric; Shiffman, Mitchell L.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

236 All Oral Fixed-Dose Combination Sofo

236 All Oral Fixed-Dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Experienced Genotype 1 HCVInfected Patients: The Phase 3 Ion-2 Study

✍ Kwo, Paul Y.; Reddy, K. Rajender; Pockros, Paul J.; Di Bisceglie, Adrian M.; Aro 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 361 KB